Comparison of the anticancer effect of free and HPMA copolymer-bound adriamycin in human ovarian carcinoma cells

Pharmaceutical Research

Volumn 16, Issue 7, 1999, Pages 986-996

  Minko, Tamara ^a   Kopečková, Pavla ^a,b   Kopeček, Jindřich ^a,b  

^a UNIVERSITY OF UTAH   (United States)

^b University of Utah   (United States)

Author keywords

Adriamycin; Apoptosis; Doxorubicin; Gene expression; HPMA copolymer; Multidrug resistance; Signal transduction

Indexed keywords

ADENOSINE TRIPHOSPHATE; DNA; DOXORUBICIN; LIPID; N (2 HYDROXYPROPYL)METHACRYLAMIDE COPOLYMER;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL METABOLISM; CELL VIABILITY; DNA DETERMINATION; DNA REPAIR; DRUG ACCUMULATION; DRUG CYTOTOXICITY; DRUG MECHANISM; GENE EXPRESSION; LIPID PEROXIDATION; OVARY CARCINOMA; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA; DOXORUBICIN; DRUG CARRIERS; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; GENE EXPRESSION; HUMANS; LIPID PEROXIDATION; OVARIAN NEOPLASMS; POLYMETHACRYLIC ACIDS; TUMOR CELLS, CULTURED;

EID: 0032766043     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018959029186     Document Type: Article

References (30)

1. M. Kool, M. de Haasde, G. L. Scheffer, R. J. Schapper, J. T. van Eijk, and J. A. Juijn. Analysis of expression of cMOAT (MRP2), MRP3, MRP4 and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res. 57:3537-3547 (1997).
2. N. Krishnamachary and M. S. Center. The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein. Cancer Res. 53:3658-3661 (1993).
3. U. A. German. P-glycoprotein: a mediator of multidrug resistance in tumour cells. Eur. J. Cancer 32A:927-944 (1996).
4. D. A. Putman and J. Kopeček. Polymer conjugates with anticancer activity. Adv. Polym. Sci. 122:55-123 (1995).
5. V. Omelyanenko, C. Gentry, P. Kopečková, and J. Kopeček. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. II. Processing in epithelial ovarian carcinoma cells in vitro. Int. J. Cancer 75:600-608 (1998).
6. H. J.-P. Ryser and W.-C. Shen. Conjugation of methotrexate to poly(L-lysine) increases drug transport and overcomes drug resistance in cultured cells. P roc. Natl. Acad,. Sci. U.S.A. 75:3867-3870 (1978).
7. rd International Symposium on Polymer Therapeutics, London, UK (1998).
8. T. Minko, P. Kopečková, V. Pozharov, and J. Kopeček. HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line. J. Contr. Rel. 54, 223-233 (1998).
9. T. Minko, P. Kopečková, and J. Kopeček. Chronic exposure to HPMA copolymer-bound adriamycin does not induce multidrug resistance in a human ovarian carcinoma cell line. J. Contr. Rel. (in press).
10. K. Kunath, P. Kopečková, T. Minko, and J. Kopeček. HPMA copolymer - anticancer drugs - OV-TL16 antibody conjugates. 3. The effect of free and polymer-bound adriamycin on the expression of same genes in the OVCAR-3 human ovarian carcinoma cell line. Eur. J. Pharm. Biopharm. (in press).
11. J. Kopeček, P. Rejmanová, J. Strohalm, K. Ulbrich, B. Říhová, V. Chytrý, J. B. Lloyd, and R. Duncan. Synthetic polymeric drugs. U.S. Pat. 5,037,883 (Aug. 6, 1991).
12. V. G. Omelyanenko, P. Kopečková, C. Gentry, J.-G. Shiah, and J. Kopeček. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 1. Influence of the methods of synthesis on the binding affinity to OVCAR-3 ovarian carcinoma cells in vitro. J. Drug Target. 3:357-373 (1996).
13. P. Rejmanová, J. Labský, and J. Kopeček. Aminolyses of monomeric and polymeric p-nitrophenyl esters of methacryloylated amino acids. Makromol. Chem. 178:2159-2168 (1977).
14. E. C. Spoelstra, H. Dekker, G. J. Schuurhuis, H. J. Broxterman, and J.P. Lankelman. Glycoprotein drug efflux pump involved in the mechanism of intrinsic drug resistance in various colon cancer cell lines. Biochem. Pharmacol. 41:349-359 (1991).
15. M. B. Hansen, S. E. Nielsen, and K. Berg. Re-examination and further development of a precise and rapid dye method for measuring cell growing/cell kill. J. Immunol. Meth. 119:203-210 (1989).
16. F. Denizot and R. Lang. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Meth. 89:271-277 (1986).
17. K. E. Noonan, C. Beck, T. A. Holzmayer, J. E. Chin, J. S. Wunder, I. L. Andrulis, A. F. Gazdar, C. L. Willman, B. Griffith, D. D. Von Hoff, and I. B. Roninson. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc. Natl. Acad. Sci. U.S.A. 87:7160-7164 (1990).
18. B. van Hille, A. Lohri, J. Reuter, and R. Rerrmann. Assessment of drug-induced dysregulations among seven resistance-associated genes in human tumor cell lines. Anticancer Res. 16:3531-3536 (1996).
19. C. M. Yuan, E. M. Bohen, F. Musio, and M. A. Carome. Sublethal heat shock and cyclosporine exposure produce tolerance against cyclosporine toxicity. Am. J. Physiol. 271:F571-F578 (1996).
20. J. E. Platt, X. He, D. Tang, J. Slater, and M. Goldstein. C-fos expression in vivo in human lymphocytes in response to stress. Prog. Neuro-Psychopharmacol. & Biol. Psychiat. 19:65-74 (1995).
21. J. Murray, V. Sheffield, J. L. Weber, G. Duyk, and K. H. Buetow. NSBI Entrez database, accession G15909, NID g1161798. (1995) (obtained through Internet: http://www.ncbi.nlm.nih.gov/Entrez/).
22. K. Yagi. Lipid peroxides and human diseaases. Chem. Phys. Lipids 45:337-351 (1987).
23. J. L.-S. Au, N. P. D. Li, and Y. Gan. Apoptosis: a new pharmacodynamic endpoint. Pharm. Res. 14:1659-1671 (1997).
24. D. W. Loe, R. G. Decley, and S. P. C. Cole. Biology of the multidrug resistance associated protein, MRP. Eur. J. Cancer 32A:945-957 (1996).
25. K. D. Tew. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res. 54:4313-4320 (1994).
26. A. Harris and D. Hochhauser. Mechanisms of multidrug resistance in cancer treatment. Acta Oncologica 2:205-213 (1992).
27. W.-J. Kim, Y. Kakehi, W.-J. Wu, M. Fukumoto, and O. Yoshida. Expression of multidrug resistance-related genes (mdrl, MRP, GST-π and DNA topoisomerase II) in urothelial cancers. Br. J. Urology 78:361-368 (1996).
28. C. Malhos, M. K. Howard, and D. S. Latchman. Heat shock protects neuronal cells from programmed cell death by apoptosis. Neuroscience 55:621-627 (1993).
29. T. R. Tritton. Cell surface actions of adriamycin. Pharm. Ther. 49:293-309 (1991).
30. B. K. Siesjö, K. I. Katsura, T. Kristián, P.-A. Li, and P. Siesjö. Molecular mechanisms of acidosis-mediated damage. Acta Neurochir. 66 (Suppl): 8-14 (1996).